tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: BELLUS Health (BLU) and AstraZeneca (AZN)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BELLUS Health (BLUResearch Report) and AstraZeneca (AZNResearch Report).

BELLUS Health (BLU)

RBC Capital analyst Gregory Renza maintained a Buy rating on BELLUS Health today and set a price target of $11.00. The company’s shares closed last Monday at $5.40.

According to TipRanks.com, Renza has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -5.5% and a 30.6% success rate. Renza covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Verrica Pharmaceuticals, and Inovio Pharmaceuticals.

BELLUS Health has an analyst consensus of Strong Buy, with a price target consensus of $11.28.

See today’s best-performing stocks on TipRanks >>

AstraZeneca (AZN)

In a report released today, Peter Welford from Jefferies downgraded AstraZeneca to Hold. The company’s shares closed last Monday at $55.41.

According to TipRanks.com, Welford is a 5-star analyst with an average return of 15.2% and a 59.4% success rate. Welford covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Sanofi, and Genmab.

Currently, the analyst consensus on AstraZeneca is a Moderate Buy with an average price target of $73.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on BLU:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed